%D8%A3%D9%88%D9%83%D8%B3%D8%A7%D9%84%D9%8A%D8%A8%D9%84%D8%A7%D8%AA%D9%8A%D9%86Category:OxaliplatinOcsaliplatinOxaliplatinOxaliplatinOxaliplatino%D8%A7%DA%A9%D8%B3%D8%A7%D9%84%DB%8C%E2%80%8C%D9%BE%D9%84%D8%A7%D8%AA%DB%8C%D9%86OksaliplatiiniOxaliplatineOxaliplatino%E3%82%AA%E3%82%AD%E3%82%B5%E3%83%AA%E3%83%97%E3%83%A9%E3%83%81%E3%83%B3%E0%AC%93%E0%AC%95%E0%AD%8D%E0%AC%B8%E0%AC%BE%E0%AC%B2%E0%AC%BF%E0%AC%AA%E0%AD%8D%E0%AC%B2%E0%AC%BE%E0%AC%9F%E0%AC%BF%E0%AC%A8OksaliplatynaOxaliplatin%C4%83%D0%9E%D0%BA%D1%81%D0%B0%D0%BB%D0%B8%D0%BF%D0%BB%D0%B0%D1%82%D0%B8%D0%BDOksaliplatinOksaliplatinOksaliplatin%D0%9E%D0%BA%D1%81%D0%B0%D0%BB%D1%96%D0%BF%D0%BB%D0%B0%D1%82%D0%B8%D0%BDOxaliplatinQ422327%E5%A5%A5%E6%B2%99%E5%88%A9%E9%93%82
about
P3354
P3781
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CarcinomaEfficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerEffect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal CancerEffects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic CancerThe Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric CancerA Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesmFLOT Chemotherapy as First-line Treatment in GCHyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer With Peritoneal MetastatisNeoadjuvant mFOLFOXIRI for Potentially Resectable CholangiocarcinomaPreoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal CancerFolfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerXELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric AdenocarcinomaSULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular CarcinomaBiweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersFOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal CancerPerioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP StudyStudy of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial TractDose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerPreoperative Radiotherapy and E7046 in Rectum CancerFOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon CancerErlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerCombination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerOxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic CancerA Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal CancerCO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaGemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanA Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXOxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisStudy of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic CancerA Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLCOxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLLCapecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal CancerStereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic CancerCetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer
P4844
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradationClinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.Oxaliplatin doublets in non-small cell lung cancer: a literature review.Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?Melatonin Attenuates Pain Hypersensitivity and Decreases Astrocyte-Mediated Spinal Neuroinflammation in a Rat Model of Oxaliplatin-Induced Pain.Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathyCYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients.miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.Oxaliplatin neurotoxicity--no general ion channel surface-charge effect.Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study.FDA drug approval summaries: oxaliplatin.Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.Oxaliplatin reacts with DMSO only in the presence of water.Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.Oxaliplatin induces muscle loss and muscle-specific molecular changes in MICE.Effect of ninjin'yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice.Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study.Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer.Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.Effects of Oxaliplatin Treatment on the Myenteric Plexus Innervation and Glia in the Murine Distal Colon[Cetuximab in association with an oxaliplatin-based chemotherapy as first-line treatment of metastatic colorectal cancer.]Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosisBazedoxifene as a novel GP130 inhibitor for Colon Cancer therapySafety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaAscorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor GrowthTumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinomaPeritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort studyInfluence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancerNonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancerThe Analgesic Effect of Venlafaxine and Its Mechanism on Oxaliplatin-Induced Neuropathic Pain in MiceEffects of oxaliplatin-containing adjuvant chemotherapy on short-term survival of patients with colon cancer in Dr. Sardjito Hospital, Yogyakarta, IndonesiaOxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II TrialsCapecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority Trial
P921
Q12048781-AEB68DAC-F466-4527-8D23-E24CB1D10420Q18553565-4A86BB60-B76D-4427-8050-D7B588A03011Q18554959-DE55B97F-3BD6-44D5-9286-D954B5B9AA18Q18555025-16FF650D-3B77-4F64-8822-E3EA93CD43A5Q18555025-D2E511B9-61AD-4B1B-9367-D9163D7B2116Q18555055-A3209F97-E73C-4834-9862-AAE1DBC00842Q18555196-EF9FEB68-7DDA-4156-AF84-5BCE9AB41AC5Q18556047-BBEA932F-9273-4006-B581-149494A6F33BQ18556189-3ED676A9-5E35-4CC5-9592-3934946E5CB5Q2739660-69FFA0A9-D9B3-476E-A913-7FFA97276778Q2739660-D4CFA44D-7B1E-4F83-9066-41E97F45D80E
P2176
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Oksaliplatiini
@fi
Oksaliplatin
@sh
Oksaliplatin
@sl
Oksaliplatin
@sr
Oxaliplatin
@de
Oxaliplatin
@nl
Oxaliplatin
@vi
Oxaliplatino
@es
Oxaliplatino
@it
Oxaliplatină
@ro
type
label
Oksaliplatiini
@fi
Oksaliplatin
@sh
Oksaliplatin
@sl
Oksaliplatin
@sr
Oxaliplatin
@de
Oxaliplatin
@nl
Oxaliplatin
@vi
Oxaliplatino
@es
Oxaliplatino
@it
Oxaliplatină
@ro
altLabel
63121-00-6
@fr
C8H14N2O4Pt
@fr
C8H14N2O4Pt
@it
Diaminocyclohexane Oxalatoplatinum
@cy
Diaminocyclohexane Oxalatoplatinum
@en
Eloxatin
@cy
Eloxatin
@en
JM-83
@cy
JM-83
@en
L-OHP
@cy
prefLabel
Oksaliplatiini
@fi
Oksaliplatin
@sh
Oksaliplatin
@sl
Oksaliplatin
@sr
Oxaliplatin
@de
Oxaliplatin
@nl
Oxaliplatin
@vi
Oxaliplatino
@es
Oxaliplatino
@it
Oxaliplatină
@ro